Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Interest coverage

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

ebit/interest expense=-65.7×

Based on trailing twelve months.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's interest coverage.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's interest coverage?
Achieve Life Sciences (ACHV) reported interest coverage of -65.7× in Q4 2025.
How has Achieve Life Sciences's interest coverage changed year-over-year?
Achieve Life Sciences's interest coverage decreased by 280.6% year-over-year, from -17.3× to -65.7×.
What is the long-term trend for Achieve Life Sciences's interest coverage?
Over 3 years (2022 to 2025), Achieve Life Sciences's interest coverage has grown at a 42.6% compound annual growth rate (CAGR), from -22.7× to -65.7×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.